Pre-Conference Workshop

A Professionally Rewarding Experience

Chronic Infections, Inflammation and Biotoxins


Thursday, April 6, 2017


Register

Research and findings have indicated that inflammation is tied to a range of various diseases, including allergies and asthma, joint disease, obesity, hay fever, and even major depressive disorders. While the body’s inflammatory response is utilized to protect and combat invading organisms like bacteria, viruses, and parasites, uncontained inflammation can ultimately lead to bodily and organ deterioration. Moreover, chronic infections generate economic and medical burdens on U.S. resources and infrastructure: In 2013, there were 36,307 new cases of Lyme disease and 50,634 cases of salmonella. Throughout 2012, there were 3.9 million outpatient hospital visits for infectious and parasitic diseases. Furthermore, biotoxins—which include numerous toxic agents that initially originate from plants, animals, and other biological sources—have contributed to the recent 2016 Zika Virus outbreak, which yielded 35,152 cases within the United States. Physicians and healthcare professionals must be equipped with the most current techniques and technologies in order to detect, prevent, and eventually treat chronic inflammation and the emerging host of infectious diseases. Perhaps most importantly, healthcare practitioners serve as the first line of defense in terms of emergency preparedness: responding to biotoxic outbreaks, incidents, and crises.


 Learning Objectives

  • Review the genomic, proteomic, and inflammatory response to Biotoxins
  • Identify the genomic and transcriptomic expressions found in Mold, Lyme and CIRS 
  • Review clinical algorithms to resolve the Chronic Inlammatory Response Syndrome (CIRS)
  • Examine the neuro-inflammatory and neuro-structural impact of CIRS on the central nervous system
  • Compare prescribed and natural protocols that assess and/or treat chronic infections

  • Session Schedule
Session Schedule

Ritchie Shoemaker, MD
CIRS: Definition and Treatment

7:30 am – 9:30 am

Break

9:30 am – 10:00 am

Keith Berndtson, MD
Acute and Chronic Lyme: From Antibiotics to CIRS

10:00 am – 11:00 am

Andrew Heyman, MD and Ritchie Shoemaker, MD
Complications in CIRS: Pulmonary hypertension, POTS and Auto-immunity

11:00 am – 11:30 am

Ritchie Shoemaker, MD
MARCoNS, Biofilms and Extracellular Products: What are those Bacteria Making?

11:30 am – 12:00 pm

Lunch

12:00 pm – 1:30 pm

Ritchie Shoemaker, MD
NeuroQuant: Volumetric Brain Assessment in Mold, Lyme and PTSD Treatment of Multi-nuclear Atrophy

1:30 pm – 2:30 pm

Jimmy Ryan, MD, PhD
Introduction to Genomics in CIRS

2:30 pm – 3:30 pm

Break

3:30 pm – 4:00 pm

Jimmy Ryan, MD, PhD
Genomics: Introduction to the missing piece: SRL, Genomics of Ribosomal and Mitochondrial Injury

4:00 pm – 4:30 pm

Ritchie Shoemaker, MD
To Treat with Transcriptomics

4:30 pm – 5:00 pm

Ritchie Shoemaker, MD and Jimmy Ryan, MD, PhD
Using a Transcriptome Report

5:00 pm – 5:30 pm

Panel Discussion
Cases in Mold, Lyme and Biotoxin Illness

5:30 pm – 6:00 pm

Close of Session

6:00 pm

Save The Date!

August 12, 2017 | Venetian/Palazzo Resort | Las Vegas, NV

Please save the date for Part II of our Chronic Infections, Inflammation, and Biotoxins Symposium. Continue your education with the next part of our series, during which instructors will further review the epidemiology of chronic infections from a global public health perspective. The second of this two part series will delve into the application of advanced diagnostic techniques for chronic infections, including nanotechnology and genomic sequencing. Lectures will also consider the integrative and comprehensive diagnostics for biotoxin exposure in special populations such as children and pregnant patients.


 Learning Objectives

  • Review the epidemiology and public health burden of Tick Born Diseases
  • Evaluate poly-microbial infections in Borrelia complex
  • Discover the important role of Biofilm formation in persistent infections
  • Apply advanced diagnostic techniques for chronic infections including nanotechnology and genomic sequencing
  • Understand the diagnostic and management process of Biotoxin exposure in special populations such as children and pregnant patients
  • Apply an integrative, comprehensive treatment approach to the Biotoxin and Chronic Infection patient

Chronic Infections Webinar

with Dr. Andrew Heyman


Watch Webinar Here